Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» orforglipron
orforglipron
Lilly Soars After Weight-Loss Pill Results Rival Ozempic’s
Yahoo/Bloomberg
Thu, 04/17/25 - 11:34 am
Eli Lilly
clinical trials
obesity
orforglipron
Ozempic
Eli Lilly Bets Big on Weight-Loss Pill With $550 Million Inventory Stockpile
US News and World Report
Thu, 02/20/25 - 06:07 pm
Eli Lilly
weight loss
obesity
clinical trials
orforglipron
3 trial readouts that could shake up the obesity market this year
Pharma Voice
Wed, 01/8/25 - 11:15 am
obesity
weight loss
Metsera
MET-097i
Skye Bioscience
nimacimab
Eli Lilly
orforglipron
clinical trials
Eli Lilly Stock Could Have a Huge Growth Catalyst in Early 2025
Motley Fool
Thu, 12/12/24 - 11:41 pm
Eli Lilly
orforglipron
Lilly links oral obesity drug to 15% weight loss, setting bar for Pfizer in blockbuster battle
Fierce Biotech
Mon, 06/26/23 - 10:00 am
Eli Lilly
obesity
orforglipron
Pfizer
Novo Nordisk
Mounjaro
ADA 2023 preview – Lilly’s oral obesity data leave room for Pfizer
EP Vantage
Wed, 06/21/23 - 10:38 am
ADA
Eli Lilly
Pfizer
diabetes
obesity
orforglipron
danuglipron
lotiglipron
Lilly steps up its oral obesity push
EP Vantage
Thu, 05/25/23 - 08:45 pm
Eli Lilly
obesity
GLP-1 agonist
orforglipron
Lilly and Pfizer fight for new territory in obesity and diabetes
EP Vantage
Thu, 12/15/22 - 10:46 am
Eli Lilly
Pfizer
obesity
diabetes
orforglipron
Mounjaro